Fiducial Markers Market

Report Code - HC2021423S | Industry - Healthcare | Published on - April, 2021 | Pages - 140 | Format -

Fiducial Markers Market by Product, Cancer Type, Modality and End User - Global Market Analysis and Forecast (2020 - 2025)




The global fiducial markers market is to increase from US$ 104 million in 2020 to US$ 129 million by 2025 with a compound annual growth rate (CAGR) of 4.4% for the period 2020-2025. Some of the prominent players in the fiducial markers market are Boston Scientific Corporation, Carbon Medical Technologies, Eckert & Ziegler, Innovative Oncology Solutions, Izi Medical Products, Medical International, Inc., Medtronic Plc, Nanovi A/S , Naslund Medical Ab, Qlrad Inc. The research report on the global fiducial markers market provides extensive competition analysis and competitive conditions. The report includes information on significant products, players, challenges and developments, and other information specific to the fiducial markers market. The global economy is highly affected by the COVID-19. Various sectors in the economy are much affected by this pandemic. It is anticipated that the global economy will decline because of the loss of trillions of dollars. The growing extension and imposition of lockdown in various countries directly affect the economy all over the world. The report consists of a chapter that provides a detailed study of the impact of COVID-19 on the fiducial markers market. The data in this report is targeted for business and industry practitioners and specifically intended to assist in the explanation, direction, and to understand the potential of the fiducial markers markets. The study focuses on providing readers with an understanding of developments in the industry, market segments, market forecasts, leading players, and market drivers and inhibitors.

  • Goals and objectives of the study
    • Understanding the opportunities and advancements of fiducial markers is determining the market highlights, along with the foremost regions and countries involved in the growth of the market.
    • To study the diverse segments of the fiducial markers market and the dynamics of fiducial markers in the market.
    • To categorize segments of fiducial markers with escalating growing potential and to value the futuristic market of the segments.
    • To analyze the major trends related to different segments that help in figuring and persuading the fiducial markers market.
    • To check region-specific growth and development in the fiducial markers market.
    • To understand the foremost stakeholders of the fiducial markers market and the value of the competitive landscape of the leaders of the fiducial markers market.
    • To study the key plans, initiatives, and strategies for the development of the fiducial markers market.

Chapter 2, Market Overview provides an overview of the fiducial markers market. The chapter includes macro-economic factors, market determinants (includes market drivers, restraints, opportunities, and challenges), value chain analysis, technology/product roadmap, Porter 5 force model analysis, market growth opportunity analysis.

Chapter 3, Segment Analysis of the study deals with the different sub-segments of the market to calculate reliable market forecasts. The chapter provides an in-depth analysis of the market segments of the fiducial markers market, year-on-year growth projections that enable readers to identify potential market growth areas.

  • Market Segmentation
    • Based on product, the global fiducial markers market is segmenting into metal-based markers, polymer-based markers, other.
    • Based on cancer type, the fiducial markers market is segmenting into breast cancer, gastric cancer, lung cancer, prostate cancer, other .
    • Based on modality, the fiducial markers market is segmenting into ct/cbct, mri, radiotherapy, ultrasound.
    • Based on end user, the fiducial markers market is segmenting into cancer research centers, hospitals & outpatient facilities, independent radiotherapy centers.

Chapter 4, Regional Analysis includes an in-depth analysis of the fiducial markers market by regions such as North America, Europe, Asia-Pacific, Middle East & Africa, and Latin America. The report also includes a comprehensive analysis of the market in key countries such as the United States, Canada, Germany, France, Italy, Spain, China, India, Japan, the GCC, South Africa, Brazil, Mexico, and the rest of the world. Regional insight helps market competitors to make crucial decisions about their company. Individualized, country-wise, and segment-wise analyses by region allow readers of the fiducial markers market report to explore the potential of the market in different geographies. For each year's growth projections and a global share of value, this section is a vital part of the report.

Chapter 5, Competitive Analysis of the report includes company shares analysis, a list of acquisitions, mergers, collaboration, and the introduction of new products.

Chapter 6, Company Profile of the report also covers key industry players working on the fiducial markers market. The report also discusses the business strategies adopted by the players at the global, regional, and country-level. The study also focuses on various businesses or inorganic business development strategies for expanding consumer networks through product formation, organization extension, partnerships, mergers, and acquisitions.

The study offers an exhaustive summary and estimate of the global fiducial markers market. It includes in-depth qualitative and quantitative analyses in the report that aligned with the goals and objectives of our customers. Projections have been confirmed by comprehensive primary and secondary analysis. The study will encourage clients to invest in the fiducial markers market based on the current business situation, trends, and potential developments in the segments. Understanding the requirement of the client, the report delivers specialist insights into the global fiducial markers market, its products, and market patterns.

1.Introduction

2.Market Overview
2.1.Global Fiducial Markers Market Introduction
2.2.Macro- Economic Factor
2.3.Market Determinants
2.3.1.Market Driver
2.3.2.Market Restraints
2.3.3.Market Opportunities
2.3.4.Market Challenges
2.4.Technology/Product Roadmap
2.5.PEST Analysis
2.6.Market Growth Opportunity Analysis
2.7.Impact of Covid-19 on Fiducial Markers Market

3.Market Segmentation
3.1.Global Fiducial Markers Market Analysis (US$ Mn), By Product, 2019 – 2025
3.1.1.Metal-Based Markers
3.1.2.Polymer-Based Markers
3.1.3.Other
3.2.Global Fiducial Markers Market Analysis (US$ Mn), By Cancer Type, 2019 – 2025
3.2.1.Breast Cancer
3.2.2.Gastric Cancer
3.2.3.Lung Cancer
3.2.4.Prostate Cancer
3.2.5.Other
3.3.Global Fiducial Markers Market Analysis (US$ Mn), By Modality, 2019 – 2025
3.3.1.CT/Cbct
3.3.2.MRI
3.3.3.Radiotherapy
3.3.4.Ultrasound
3.4.Global Fiducial Markers Market Analysis (US$ Mn), By End User, 2019 – 2025
3.4.1.Cancer Research Centers
3.4.2.Hospitals & Outpatient Facilities
3.4.3.Independent Radiotherapy Centers

4.Regional Analysis
4.1.North America Fiducial Markers Market Analysis (US$ Mn), 2019 - 2025
4.1.1.By Country
4.1.1.1.U.S.
4.1.1.2.Canada
4.1.2.By Product
4.1.3.By Cancer Type
4.1.4.By Modality
4.1.5.By End User
4.2.Europe Fiducial Markers Market Analysis (US$ Mn), 2019 - 2025
4.2.1.By Country
4.2.1.1.Germany
4.2.1.2.U.K.
4.2.1.3.France
4.2.1.4.Italy
4.2.1.5.Spain
4.2.1.6.Rest of Europe
4.2.2.By Product
4.2.3.By Cancer Type
4.2.4.By Modality
4.2.5.By End User
4.3.Asia Pacific Fiducial Markers Market Analysis (US$ Mn), 2019 - 2025
4.3.1.By Country
4.3.1.1.China
4.3.1.2.Japan
4.3.1.3.India
4.3.1.4.Rest of Asia Pacific
4.3.2.By Product
4.3.3.By Cancer Type
4.3.4.By Modality
4.3.5.By End User
4.4.Middle East & Africa Fiducial Markers Market Analysis (US$ Mn), 2019 - 2025
4.4.1.By Country
4.4.1.1.GCC
4.4.1.2.South Africa
4.4.1.3.Rest of Middle East & Africa
4.4.2.By Product
4.4.3.By Cancer Type
4.4.4.By Modality
4.4.5.By End User
4.5.Latin America Fiducial Markers Market Analysis (US$ Mn), 2019 - 2025
4.5.1.By Country
4.5.1.1.Brazil
4.5.1.2.Mexico
4.5.1.3.Rest of Latin America
4.5.2.By Product
4.5.3.By Cancer Type
4.5.4.By Modality
4.5.5.By End User

5.Company Profiles
5.1.Boston Scientific Corporation
5.2.Carbon Medical Technologies
5.3.Eckert & Ziegler
5.4.Innovative Oncology Solutions
5.5.Izi Medical Products
5.6.Medical International, Inc.
5.7.Medtronic Plc
5.8.Nanovi A/S
5.9.Naslund Medical Ab
5.10.Qlrad Inc.

Request for Sample Report


Full Name
Company
Job Title/Designation
Business Email
Address
Country
Contact Number
Description
I acknowledge that I have read the Privacy Policy

Inquiry Before Buying


Full Name
Company
Job Title/Designation
Business Email
Address
Country
Contact Number
Description
I acknowledge that I have read the Privacy Policy

Speak to Analyst


Full Name
Company
Job Title/Designation
Business Email
Address
Country
Contact Number
Description
I acknowledge that I have read the Privacy Policy